The Standard of Care for Evaluating Metastatic Risk in Your Newly Diagnosed Uveal Melanoma Patients The Standard of Care for Evaluating Metastatic Risk in Your Newly Diagnosed Uveal Melanoma Patients DecisionDx®-UM Overview Genomic testing with DecisionDx-UM enables accurate assessment of metastatic risk. Clinical Validation DecisionDx-UM is extensively researched including multiple prospective studies. Test Process Learn more about the straightforward ordering process for DecisionDx-UM. Scientific References DecisionDx-UM is supported by 19 peer-reviewed publications. Resources A broad range of resources are available to support the use of DecisionDx-UM. Additional Uveal Melanoma Tests Additional DecisionDx tests designed to improve the treatment and management of uveal melanoma.
